secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longevity Health Holdings, Inc. (XAGE)
CIK:        0001842939
Form:       8-K
Filed at:   2025-06-25T23:59:59+00:00
Accession:  0000950170-25-090015
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Longevity Health extends merger deadline with 20/20 Biolabs to July 8, 2025
---------------------------------------------------------------------------

- Due Diligence Contingency Deadline moved to July 8, 2025; merger agreement will auto-terminate on that date unless extended in writing.
- Amendment signed June 24, 2025; original Agreement and Plan of Merger dated April 11, 2025.
- No other provisions of the merger agreement were modified beyond the deadline extension.
- Parties: Longevity Health Holdings, Merger Sub, 20/20 Biolabs, and stockholder representative Jonathan Cohen.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1842939/000095017025090015/0000950170-25-090015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1842939/000095017025090015/xage-20250624.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-090015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer